de Nooijer, R <br/><br/>
Leukocyte cathepsin S is a potent regulator of both cell and matrix turnover in advanced atherosclerosis.  [electronic resource] 

 -  Arteriosclerosis, thrombosis, and vascular biology  Feb 2009 
 - 188-94 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1524-4636 
<br/><br/><label>Standard No.: </label>10.1161/ATVBAHA.108.181578  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Aorta--enzymology<br/>Apoptosis<br/>Atherosclerosis--enzymology<br/>Bone Marrow Transplantation<br/>Cathepsins--antagonists & inhibitors<br/>Cell Movement<br/>Cell Proliferation<br/>Cells, Cultured<br/>Cholesterol--metabolism<br/>Collagen--metabolism<br/>Diet, Atherogenic<br/>Disease Models, Animal<br/>Elastic Tissue--metabolism<br/>Extracellular Matrix--metabolism<br/>Female<br/>Foam Cells--enzymology<br/>Leukocytes--drug effects<br/>Macrophages, Peritoneal--enzymology<br/>Mice<br/>Mice, Knockout<br/>Myocytes, Smooth Muscle--metabolism<br/>Necrosis<br/>Protease Inhibitors--pharmacology<br/>Receptors, LDL--deficiency<br/>Transplantation Chimera